Drawing for SUPPLYRX

USPTO serial 88380097

SUPPLYRX

Reviewed by CopyMark Law Group

Reg. 6081319Status 702Renewal
Filing date
Status date
Registration date
Jun 16, 2020
Examiner
SAKAI, ADA HAN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SUPPLYRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kurt D. Olender, Esq.

Kurt D. Olender, Esq. OLENDERFELDMAN LLP422 MORRIS AVESUMMIT, NJ 07091United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management services in the field of pharmaceutical commercial and clinical research, namely, providing point of sale and free trial offers to improve the efficiency of delivering commercial and clinical study medicine and supplies to patients or subjects participating in clinical studies; Business consulting and management services in the field of scientific and clinical trials, namely, providing management of programs that assist patients with initiating and continuing consumption of medications to improve the efficiency of delivering clinical and scientific study medicine and supplies to subjects participating in clinical studiesACTIVEJan 15, 2020
042Scientific and clinical research services, namely, consulting and management services in the field of pharmaceuticals pertaining to creating and designing programs to improve the efficiency of delivering clinical and scientific study medicine and supplies to subjects participating in clinical studiesACTIVEJan 15, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 13, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 13, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 13, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 9, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jun 16, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 12, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 11, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 8, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 8, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 23, 2020IUAFUSE AMENDMENT FILED—
Mar 23, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 1, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 20, 2019DOCKASSIGNED TO EXAMINER—
Apr 27, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance